Determination of growth fraction and cell density to evaluate the potential growth of human oligodendroglial and astrocytic tumours

Journal of Cancer Research and Clinical Oncology

Volumn 124, Issue 8, 1998, Pages 427-434

  Gordower, Laurence ^a   Decaestecker, Christine ^a   Lopes, Maria Beatriz ^b   Camby, Isabelle ^a   Nagy, Nathalie ^c   François, Christine ^a   Cras, Patrick ^d   Martin, Jean Jacques ^d   Brotchi, Jacques ^c   Kiss, Robert ^a   Salmon, Isabelle ^c  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^c ERASME HOSPITAL   (Belgium)

^d UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Cell density; Cell loss; Cell proliferation; Gliomas; Growth fraction

Indexed keywords

MONOCLONAL ANTIBODY KI 67;

APOPTOSIS; ARTICLE; ASTROCYTOMA; CANCER GRADING; CELL DENSITY; CELL KINETICS; CELL LOSS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MICROSCOPY; OLIGODENDROGLIOMA; PRIORITY JOURNAL; TUMOR GROWTH;

ADULT; AGED; AGED, 80 AND OVER; ASTROCYTOMA; BRAIN NEOPLASMS; CELL COUNT; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; OLIGODENDROGLIOMA; PREDICTIVE VALUE OF TESTS;

EID: 7344233692     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004320050195     Document Type: Article

References (44)

1. Bigras G, Marcelpoil R, Brambilla E, Brugal G (1996) Interest of targeting AgNORs measurement in cycling cells: in vivo cell kinetic evaluation of non-small cell lung cancers. Anal Cell Pathol 11:183-198
2. Bruner JM (1994) Neuropathology of malignant gliomas. Semin Oncol 21:126-138
3. Burger PC, Vogel FS, Green SB, Strike TA (1985) Glioblastoma multiforme and anaplastic astrocytoma. Pathologic criteria and prognostic implications. Cancer 56:1106-1111
4. Burger PC, Shibata T, Kleihues P (1986) The use of the monoclonal antibody Ki-67 for the identification of proliferating cells: application to surgical neuropathology. Am J Surg Pathol 10:611-617
5. Carbajo S, Orfao A, Vicente-Villardon JL, Carbaajo-Perez E (1993) Expression of silver nucleolar organizer regions is coupled to cell cycle in rat thymic cells. Cytometry 14:46-52
6. Cattoretti G, Becker MH, Key G, Duchrow M, Schulter C, Galle J, Gerdes J (1992) Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB1 and MIB3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 168:357-363
7. Coons SW, Johnson BW (1993) Regional heterogeneity in the proliferative activity of human gliomas as measured by the Ki67 labeling index. J Neuropathol Exp Neurol 52:609-618
8. Coons SW, Johnson PC, Pearl DK, Olafsen AG (1994) Prognostic significance of flow cytometry deoxyribonucleic acid analysis of human oligodendroaliomas. Neurosurecry 34:680-687
9. Coons SW, Johnson PC, Scheithauer BW, Yates AJ, Pearl DK (1997) Improving diagnostic accuracy and interobserver concordance in the classification and grading of primary gliomas. Cancer 79:1381-1393
10. Decaestecker C, Salmon I, Camby I, Dewitte O, Pasteels JL, Brotchi J, Van Ham P, Kiss R (1995) Identification of high versus lower risk clinical subgroups in a group of adult patients with supratentorial anaplastic astrocytomas. J Neuropathol Exp Neurol 54:371-384
11. Decaestecker C, Lopes MB, Gordower L, Camby I, Cras P, Martin J-J, Kiss R, VandenBerg S, Salmon I (1997a) Quantitative chromatin pattern description in Feulgen-stained nuclei as a diagnostic tool to characterize the oligodendroglial and astroglial components in mixed oligoastrocytomas. J Neuropathol Exp Neurol 56:391-402
12. Decaestecker C, Salmon I, DeWitte O, Camby I, Van Ham Ph, Pasteels JL, Brotchi J, Kiss R (1997b). Nearest-neighbour method of classification for the identification of aggressive versus non-aggressive low-grade astrocytic tumours by means of image-cytometry-generated variables. J Neurosurg 86:532-537
13. Evan G (1997) Cancer: a matter of life and cell death. Int J Cancer 71:709-711
14. Gerdes J, Schwab U, Lemke H, Stein H (1983) Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 31:13-20
15. Goldschmidt D, Decaestecker C, Berthe JV, Gordower L, Remmelink M, Danguy A, Pasteels JL, Salmon I, Kiss R (1996) The contribution of image cytometry and artificial intelligence-related methods of numerical data analysis for adipose tumour histopathologic classification. Lab Invest 75:295-306
16. Gratas C, Tohma Y, Van Meir EG, Klein M, Tenan M, Ishii N, Tachibana O, Kleihues P, Ohgaki H (1997) Fas ligand expression in glioblastoma cell lines and primary astrocytic brain tumours. Brain Pathol 7:863-869
17. Hoshino T, Barker M, Wilson CB (1975) The kinetics of cultured human glioma cells: autoradiographic studies. Acta Neuropathol (Berl) 32:235-244
18. Hoshino T, Ahn D, Prados MD, Lamborn K, Wilson CB (1993) Prognostic significance of the proliferative potential of intracranial gliomas measured by bromodeoxyuridine labeling. Int J Cancer 53:550-555
19. Khoshyomn S, Maier H, Morimura T, Kitz K, Budka H (1993) Immunostaining for proliferating cell nuclear antigen: its role in determination of proliferation in routinely processed human brain tumour specimens. Acta Neuropathol (Berl) 86:582-589
20. Kiss R, DeWitte O, Decaestecker C, Camby I, Gordower L, Delbecque K, Pasteels JL, Brotchi J, Salmon I (1997) The combined determination of proliferative activity and cell density to identify short-as opposed to long-surviving adult patients with supratentorial high-grade astrocytic tumours. Am J Clin Pathol 107:321-331
21. Kleihues P, Burger PC, Scheithauer BW (eds) (1993) Histological typing of tumours of the central nervous system. World Health Organisation international histological classification of tumours, 2nd edn. Springer, Berlin Heidelberg New York
22. Kleihues P, Soylemezoglou F, Schauble B, Scheithauer BW, Burger PC (1995) Histopathology classification, and grading of gliomas. GLIA 15:211-221
23. Krajewski S, Krajewska M, Ehrmann J, Sikorska M, Lach B, Chatten J, Reed JC (1997) Immunohistochemical analysis of Bcl-2, Bcl-X, Mcl-1 and Bax in tumours of central and peripheral nervous system origin. Am J Pathol 150:805-814
24. Liu XZ, Xu XM, Hu R, Zhang SX, McDonald JW, Dong HX, Wu YJ, Fan GS, Jacquin MF, Hsu CY, Choi DW (1997) Neuronal and glial apoptosis after traumatic spinal cord injury. J Neurosci 17:5395-5406
25. Louis DN (1997) A molecular genetic model of astrocytoma histopathology. Brain Pathol 7:755-764
26. Maier H, Morimura T, Ofner D, Hallbrucker C, Kitz K, Budka H (1990) Argyrophylic nucleolar organizer region proteins (AgNORs) in human brain tumours: relations with grade of malignancy and proliferation indices. Acta Neuropathol (Berl) 80:156-162
27. McKeever PE, Ross DA, Strawderman MS, Brunberg JA, Greeberg HS, Junck L (1997) A comparison of the predictive power for survival in gliomas provided by MIB-1, bromodeoxyuridine and proliferating cell nuclear antigen with histopathologic and clinical parameters. J Neuropathol Exp Neurol 56:798-805
28. McKeown MJ, Ramsay DA (1996) Classification of astrocytomas and malignant astrocytomas by principal components analysis and a neural net. J Neuropathol Exp Neurol 55:1238-1245
29. Mittler MA, Walters BC, Stopa EG (1996) Observer reliability in histological grading of astrocytoma stereotactic biopsies. J Neurosurg 85:1091-1094
30. Morimura T, Kitz K, Budka H (1989) In situ analysis of cell kinetics in human brain tumours. A comparative immunocytochemical study of S phase cells by a new in vitro bromodeoxyuridine-labeling technique, and of proliferating pool cells by monoclonal antibody. Acta Neuropathol (Berl) 77:276-282
31. Noble M, Gutowski N, Bevan K, Engel U, Linskey M, Urenjak J, Bhakoo K, Williams S (1995) From rodent glial precursor cell to human glial neoplasia in the oligodendrocyte-type-2-astrocyte lineage. GLIA 15:222-230
32. Öfner D, Hittmaier A, Marth C, Öfner C, Tosch M, Daxenbichler G, Mikuz G, Margreiter R, Schmid KW (1992) Relationship between quantity of silver stained nucleolar organizer regions associated proteins (AgNORs) and population doubling time in ten breast cancer cell lines. Pathol Res Pract 188:742-746
33. Onda K, Davis RL, Shibuya M, Wilson CB, Hoshino T (1994) Correlation between the bromodeoxyuridine labeling index and the MIB1 and Ki-67 proliferating cell indices in cerebral gliomas. Cancer 74:1921-1926
34. Patsouris E, Davaki P, Kapranos N, Davaris P, Papageorgiou K (1996) A study of apoptosis in brain tumours by in situ end-labeling method. Clin Neuropathol 15:337-341
35. Pertuiset B, Dougherty D, Cromeyer C, Hoshino T, Berger M, Rosenblum ML (1985) Stem cell studies of human malignant brain tumours. Part 2. Proliferation kinetics of brain-tumour cells in vitro in early-passaue cultures. J Neurosurg 63:426-432
36. Revesz T, Alsanjari N, Darling JL, Scaravilli F, Lane DP, Thomas DG (1993) Proliferating cell nuclear antigen (PCNA): expression in samples of human astrocytic gliomas. Neuropathol Appl Neurobiol 19:152-158
37. Rowan S, Fisher DE (1997) Mechanisms of apoptotic cell death. Leukemia 11:457-465
38. Salmon I, Kiss R (1993) Relationship between proliferative activity and ploidy level in a series of 530 human brain tumors including astrocytomas, meningiomas, schwannomas and metastases. Hum Pathol 24:329-335
39. Schiffer D (1990) Glioma malignancy and its biological and histological correlates. J Neurosurg Sci 34:163-165
40. Schröder R, Bien K, Kott R, Meyers I, Vossing R (1991) The relationship between Ki-67 labeling and mitotic index in gliomas and meningiomas: demonstration of the variability of the intermitotic cycle time. Acta Neuropathol (Berl) 82:389-394
41. Shibuya M, Ito S, Miwa T, Davis RL, Wilson CB, Hoshino T (1993) Proliferative potential of brain tumors. Analyses with Ki-67 and anti-DNA polymerase alpha monoclonal antibodies, bromodeoxyuridine labeling, and nuclear orizanizer region counts. Cancer 71: 189-206.
42. Shiraishi T, Tabuchi K, Mineta T, Momozaki N, Takagi M (1991). Nucleolar organizer regions in various human brain tumors. J Neurosurg 74:979-984
43. Tachibana O, Nakazawa H, Lampe J, Watanabe K, Kleihues P, Ohgaki H (1995) Expression of Fas/APO-1 during the progression of astrocytomas. Cancer Res 55:5528-5530
44. Von Deimling A, Louis DN, Wiestler OD (1995) Molecular pathways in the formation of gliomas. GLIA 15:328-338